Search
for

    Sort by

    Research 31–60 of 100

    1. Le point de vue du pathologiste concernant l’étude PCPT Progrès en Urologie · 2008
    2. Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points 2019 · 5 citations
    3. Role of 5 alpha-reductase inhibitors in the management of prostate cancer Clinical interventions in aging · 2006 · 15 citations
    4. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia? Mayo Clinic Proceedings · 2006
    5. Finasteride-its impact on sexual function and prostate cancer Journal of Cutaneous and Aesthetic Surgery · 2009 · 33 citations
    6. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    7. The Effect of 5 -Reductase Inhibitors on Erectile Function International Journal of Andrology · 2008 · 31 citations
    8. Hair, Hormones, and High-Risk Prostate Cancer Journal of Clinical Oncology · 2014 · 3 citations
    9. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    10. Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint Hair transplant forum international · 2016
    11. Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells The Journal of Urology · 2008 · 25 citations
    12. Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases The Journal of Steroid Biochemistry and Molecular Biology · 2013 · 51 citations
    13. Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome Skin appendage disorders · 2016 · 33 citations
    14. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    15. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    16. Oral medications for central serous chorioretinopathy: a literature review Eye · 2019 · 14 citations
    17. Reply Urology · 2009
    18. 5ARI and PSA: open questions Urologia Journal · 2014
    19. Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model European Urology Focus · 2026
    20. Scientific opinion on the tolerable upper intake level for selenium EFSA journal · 2023 · 30 citations
    21. Dutasteride Drugs · 2008 · 45 citations
    22. Prostate Cancer Early Detection, Version 2.2015 Journal of the National Comprehensive Cancer Network · 2015 · 67 citations
    23. Provenge is Talk of GU Malignancies Congress Oncology Times · 2010
    24. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    25. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005 · 3 citations
    26. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    27. The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression Korean Journal of Urology · 2014 · 75 citations
    28. Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review Sexual medicine reviews · 2013 · 35 citations
    29. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    30. The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being Current Sexual Health Reports · 2015 · 1 citations